FG Imperii Acquisition
FGII · NASDAQ
About FGII
- Employees
- 0
- Headquarters
- Itasca, Illinois
- Listed
- Jan 16, 2026
- Sector
- N/A
- Industry
- N/A
FGII key statistics
- Market cap
- 347.31M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 69.83K
- Volume
- 8.49K
- Open price
- $10.03
- High today
- $10.03
- Low today
- $10.03
- 52 Week high
- $10.04
- 52 Week low
- $9.86
FG Imperii Acquisition (FGII) at a glance
FG Imperii Acquisition (FGII) last traded at $10.03, with a market cap of 347.31M and a price-to-earnings ratio of 0.00.
Volume so far is 8.49K shares, below the average of 69.83K shares a day.
Over the past year FG Imperii Acquisition has ranged from $9.86 to $10.04, and now sits 94% of the way up that range.
FGII news
- Press releasePRNewswire
- Press releasePRNewswire
FG Imperii Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing March 9, 2026
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.